Grepafloxacin
![Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set](http://data.docslib.org/img/264x/135084d885a0ce0d8ef8f9f83426c79a.webp)
Top View
- Research Penicillins Vs Trimethoprim-Based Regimens for Acute Bacterial Exacerbations of Chronic Bronchitis Meta-Analysis of Randomized Controlled Trials
- A Novel Predictive Model for the Anti-Bacterial, Anti-Malarial and Herg Cardiac QT Prolongation Properties of Fluoroquinolones Clifford Fong
- Methods for Treating Bacterial Infection
- From Chloroquine to Antineoplastic Drugs? the Story of Antibacterial Quinolones
- Pharmaceutical Appendix to the Harmonized Tariff Schedule
- Evaluation of Azithromycin, Trovafloxacin and Grepafloxacin As Prophylaxis for Experimental Murine Melioidosis Dermot J
- In Vivo Diagnostic Tests in Adverse Reactions to Quinolones M Venturini Díaz, T Lobera Labairu, MD Del Pozo Gil, a Blasco Sarramián, I González Mahave
- Pharmaceuticals Appendix
- Concept ID Name Class 1319998 Acebutolol Adrenergics 1154343
- Quinolones a Systematic Quest
- W O 2019/074870 a L 18 April 2019 (18.04.2019) W 1P O PCT
- Critically Important Antimicrobials for Human Medicine
- Quinolones: Mechanism, Lethality and Their Contributions to Antibiotic Resistance
- ARPEC Protocol for Drug Utilization Study
- MPHM14 Antibacterial Chemotherapy OSPAP Programme
- Factors Influencing Fluoroquinolone Resistance
- Antibacterial Drugs Antibiotics: Commercial Aspects
- Quinolone Synthesis